Vasoactive intestinal peptide enhances immunoglobulin production and growth in human plasma cells via mechanisms that may involve protein kinase C

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 8, 1996, Pages 3024-3032

  Kimata, Hajime ^a,e   Yoshida, Akira ^b   Ishioka, Chihiro ^c   Fujimoto, Masayuki ^d   Furusho, Kenshi ^e  

^a Department of Pediatrics   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c Shimada Municipal Hospital   (Japan)

^d National Hospital Organization   (Japan)

^e KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; BETA ENDORPHIN; CALCITONIN GENE RELATED PEPTIDE; CHOLECYSTOKININ OCTAPEPTIDE; GROWTH HORMONE; IMMUNOGLOBULIN; INTERLEUKIN 6; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; NEUROKININ A; NEUROPEPTIDE Y; PEPTIDE YY; PHORBOL DIBUTYRATE; PROTEIN KINASE C; SOMATOMEDIN C; SOMATOSTATIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LEUKEMIA CELL LINE; PLASMA CELL; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL;

CELL DIVISION; CELL LINE; HUMANS; IMMUNOGLOBULINS; KINETICS; NEUROPEPTIDES; PLASMA CELLS; PROTEIN KINASE C; RECEPTORS, NEUROPEPTIDE; SENSITIVITY AND SPECIFICITY; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0029787438     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.8.3024     Document Type: Article

References (54)

1. Kordan C, Bihoreau C. 1989 Integrated communication between the nervous, endocrine, and immune systems. Horm Res. 31:100-104.
2. Kawano M, Hirano T, Masuda T, et al. 1988 Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature. 332:83-85.
3. Satoh T, Nakamura S, Taga T, et al. 1988 Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukm 6. Mol Cell Biol. 8:3546-3549.
4. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A. 1989 On the cellular source and function of interleukin 6 produced in the central nervous system in viral disease. Eur J Immunol. 19:689-694.
5. Kimata H, Yoshida A, Ishioka C, Kusunoki T, Hosoi S, Mikawa H. 1991 Nerve growth factor specifically induces human IgG4 production. Eur J Immunol. 21:137-141.
6. Kimata H, Yoshida A, Ishioka C, Mikawa H. 1991 Stimulation of Ig production and growth of human lymphoblastoid B-cell lines by nerve growth factor. Immunology. 72:451-452.
7. Vandvik B, Norrby E. 1973 Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis. Proc Natl Acad Sci USA. 70:1060-1063.
8. Tourtellotte WW, Ma BI. 1978 Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis. Neurology. 76:76-83.
9. Jiang Y, Yoshida A, Ishioka C, Kimata H, Mikawa H. 1992 Parathyroid hormone inhibits immunoglobulin production without affecting cell growth in human B cells. Clin Immunol lmmunopathol. 65:286-293.
10. Degiannis D, Mowat AM, Galloway E, et al. 1987 In vitro analysis of B lymphocyte function in uremia. Clin Exp Immunol. 70:463-470.
11. Shasha SM, Kristal B, Steinberg O, Makov UE. 1989 Effect of parathyroidectomy on T cell functions in patients with primary hyperparathyroidism. Am J Nephrol. 9:25-29.
12. Kimata H, Yoshida A. 1994 Effect of growth hormone and insulin-like growth factor-I on immunoglobulin production by and growth of human B cells. J Clin Endocrinol Metab. 78:635-641.
13. Kimata H, Fujimoto M. 1994 Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells. J Exp Med. 180:729-732.
14. Fleisher TA, White RM, Broder S, et al. 1980 X-linked hypogammaglobulinemia and isolated growth hormone deficiency. N Engl J Med. 302:1429-1434.
15. Sitz KV, Burks AW, Wiliams LW, Kemp SF, Steele RW. 1990 Confirmation of X-linked hypogammaglobulinemia and isolated growth hormone deficiency as a disease entity. J Pediatr. 116:292-294.
16. Kimata H, Yoshida A, Fujimoto M, Mikawa H. 1993 Effect of vasoactive intestinal peptide, somatostatin, and substance P on spontaneous IgE and IgG4 production in atopic patients. J Immunol. 150:4630-4640.
17. Stanisz AM, Befus D, Bienenstock J. 1986 Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol. 136:152-156.
18. Laurenzi MA, Persson MAA, Dalsgaard C-J, Ringdén O. 1989 Stimulation of human B lymphocyte differentiation by the neuropeptides substance P and neurokinin A. Scand J Immunol. 30:695-701.
19. Johnson HM, Smith EC, Torres BA, Blalock JE. 1982 Regulation of the in vitro antibody response by neuroendocrine hormone. Proc Natl Acad Sci USA. 79:4171-4174.
20. Blue-Pajot MT, Mounier F, Léonard JF, Kordon C, Durand D. 1987 Vasoactive intestinal peptide induces a transient release of growth hormone in the rat. Peptides. 8:35-38.
21. Spangelo BL, Isakson PC, MacLeod RM. 1990 Production of interleukin-6 by anterior pituitary cells is stimulated by increased mtracellular adenosine 3′,5′-monophosphate and vasoactive intestinal peptide. Endocrinology. 127:403-409.
22. Kimata H, Yoshida A, Ishioka C, Jiang Y, Mikawa H. 1992 Eosinophil cationic protein inhibits immunoglobulin production and proliferation in vitro in human plasma cells. Cell Immunol. 141:422-432.
23. Sidell N,Taga T, Hirano T, Kishimoto T, Saxon A. 1991 Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. J Immunol. 146:3809-3814.
24. Portier M, Zhang X-G, Caron E, Lu Z-Y, Bataille R, Klein B. 1993 γ-Interferon in multiple myeloma: inhibition of interleukin-6 (IL-6)-dependent myeloma cell growth and down-regulation of IL-6-receptor expression in vitro. Blood. 81:3076-3082.
25. Kimata H, Yoshida A. 1994 Differential effect of growth hormone and insulinlike growth factor-1, insulin-like growth factor-II, and insulin on Ig production and growth in human plasma cells. Blood. 83:1569-1574.
26. Payan DG, Brewster DR, Goetzel EJ. 1984 Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts. J Immunol. 133:3260-3265.
27. O'dorisio MS, Shannon BT, Fleshman DJ, Campolito LB. 1989 Identification of high-affinity receptors for vasoactive intestinal peptide on human lymphocytes on B cell lineage. J Immunol. 142:3533-3536.
28. Finch RJ, Speedharan SP, Gortzl EJ. 1989 High-affinity receptors for vasoactive intestinal peptide on human myeloma cells. J Immunol. 142:1977-1981.
29. Scicchhitano P, Dazin P, Bienenstock J, Payan FG, Stanisz AN. 1988 The murine IgA-secreting plasmacytoma MOPC-315 expresses somatostatin receptors. J Immunol. 141:937-941.
30. Ishioka C, Yoshida A, Kimata H, Mikawa H. 1992 Vasoactive intestinal peptide (VIP) stimulates Ig production and growth of human B cells. Clin Exp Immunol. 87:504-508.
31. Kimata H, Yoshida A, Ishioka C, Mikawa H. 1992 Differential effect of vasoactive intestinal peptide, somatostatin, and substance P on human IgE and IgG subclass production. Cell Immunol. 144:429-442.
32. Kimata H, Fujimoto M. 1995 Induction of IgA1 and IgA2 production in immature human fetal B cells and pre-B cells by vasoactive intestinal peptide. Blood. 85:2098-2104.
33. Iwato K, Kawano M, Asaoku H, Tanabe O, Tanaka H, Kuramoto A. 1988 Separation of human myeloma cell from bone marrow aspirates in multiple myeloma and their proliferation and M-protein secretion in vitro. Blood. 72:562-566.
34. Duperray C, Klein B, Durie BGM, et al. 1989 Phenotypic analysis of human myeloma cell lines. Blood. 73:566-572.
35. Andersen KC, Park EK, Bates MP, et al. 1983 Antigens on human plasma cells identified by monoclonal antibodies. J Immunol. 130:1132-1138.
36. Kimata H, Yoshida A. 1994 Differential effects of gangliosides on Ig production and proliferation by human B cells. Blood. 84:1193-1200.
37. Kimata H, Lindley I. 1994 Interleukin-8 differentially modulates interleukin-4-and interleukin-2-induced human B cell growth. Eur J Immunol. 24:3237-3240.
38. Kimata H, Sherr EH, Saxon A. 1988 Human natural killer (NK) cells produce a late-acting B-cell differentiation activity. J Clin Immunol. 8:381-389.
39. O'dorisio MS, Hermina NS, O'doriso TM, Balcerzak SP. Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase. J Immunol. 127:2551-2554.
40. Dorflinger LJ, Schonbrun A. 1983 Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells. Endocrinology 113:1551-1558.
41. Vazquez A, Auffredou MT, Galanaud P, Leca G. 1991 Modulation of IL-2- and IL-4-dependent human B cell proliferation by cyclic AMP. J Immunol. 146:4222-4227.
42. Fujimoto J, Gershengorn MC. 1991 Evidence for dual regulation by protein kinase A and C of thyrotropin-releasing hormone receptor mRNA in GH, cells. Endocrinology. 129:3430-3432.
43. Kimata H, Fujimoto M, Lindley I, Furusho K. 1995 Interleukin 8 (IL-8) inhibits the interleukin 4 (IL-4)-induced but not the spontaneous growth of human B cells via mechanisms that may involve protein kinase C. Biochem Biophys Res Commun. 207:1044-1050.
44. Vazquez A, Auffredou MT, Chaouchi N, et al. 1991 Differential inhibition of interleukin 2- and interleukin 4-mediated human B cell proliferation by ionomycin: a possible regulatory role for apoptosis. Eur J Immunol. 21:2311-2316.
45. Shearer WT, Gilliam EB, Rosenblatt HM, Barton KS, Orson FM. 1988. Phorbol ester binding to a human lymphoblastoid B-cell line, LA350, stimulates 32P incorporation into selected phospholipids and immunoglobulin secretion. Cell Immunol. 111:316-331.
46. Hattori N, Shimatsu A, Sugita M, Kumagai S, Imura H. 1990 Immunoreactive growth hormone (GH) secretion by human lymphocytes: augmented release by GH. Biochem Biophys Res Commun. 168:396-401.
47. Merimee TJ, Grant MB, Broder CM, Cavalli-Sforza LL. 1989 Insulin-like growth factor secretion by human B-lymphocytes: a comparison of cells from normal and pygmy subjects. J Clin Endocrinol Metab. 69:978-984.
48. Gilbert KM, Hoffmann MK. 1985 cAMP is an essential signal in the induction of antibody production by B cells but inhibits helper function of T cells. J Immunol. 135:2084-2089.
49. Shearer WT, Patke CL, Gilliam EB, Rosenblatt HM, Barron KS, Orson FM. 1988 Modulation of a human lymphoblastoid B cell line by cyclic AMP. Ig secretion and phosphatidylcholine metabolism. J Immunol. 141:1678-1686.
50. Kimata H, Yoshida A, Ishioka C, Mikawa H. 1991 Nerve growth factor inhibits immunoglobulin production by but not proliferation of human plasma cell lines. Clin Immunol Immunopathol. 60:949-954.
51. Zubler CE, Galizzi J-P, Vallé A, Harada N, Howard M, Banchereau J. 1990 Interleukin 4 receptors on normal human B lymphocytes: characterization and regulation. Eur J Immunol. 20:551-555.
52. Pearse AGE, Polax JM, Bloom SR. 1977 The newer gut hormones. Cellular sources, physiology, pathology, and clinical aspects. Gastroenterology. 72:746-761.
53. Annibale B, Fais S, Boirivant M, Fave GD, Pallone F. 1990 Effects of high in vivo levels of vasoactive intestinal polypeptide on function of circulating lymphocytes in humans. Gastroenterology. 98:1693-1698.
54. Arnaout MA, Garthwaite TL, Martinson DR, Hagen TC. 1986 Vasoactive intestinal polypeptide is synthesized in anterior pituitary tissue. Endocrinology. 119:2052-2057. ANOVA.